Trials / Completed
CompletedNCT06169930
Development and Validation of a Survival Prediction Model for Esophageal Cancer Patients After Esophagectomy
Development and Validation of A Overall Survival Prediction Model for Esophageal Squamous Cell Carcinoma: A Novel pN Classification
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,957 (actual)
- Sponsor
- Yongtao Han · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- —
Summary
In this retrospective study, we analyzed data from the Sichuan Cancer Hospital \& Institute Esophageal Cancer Case Management Database (SCH-ECCM Database) from January 2010 to December 2017. Our study focused on examining the clinicopathological characteristics, lymph node removal at each station, and treatment details of patients with esophageal squamous cell carcinoma (ESCC) who underwent esophagectomy. Using this data, we developed a prediction model for OS by considering a combination of clinical characteristics and details of lymphadenectomy variables.
Detailed description
In this retrospective study, we analyzed data from the Sichuan Cancer Hospital \& Institute Esophageal Cancer Case Management Database (SCH-ECCM Database) from January 2010 to December 2017. Our study focused on examining the clinicopathological characteristics, lymph node removal at each station, and treatment details of patients with esophageal squamous cell carcinoma (ESCC) who underwent esophagectomy. Using this data, we developed a prediction model for OS by considering a combination of clinical characteristics and details of lymphadenectomy variables. Additionally, the receiver operating characteristic curve demonstrated an area under the curve greater than 0.7 at 1, 3, and 5 years in both the verification and training groups. Furthermore, Kaplan-Meier (K-M) curves showed that our model effectively distinguished between high- and low-risk groups (p \< 0.01).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | This was an observational study without any intervention | This was an observational study without any intervention |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2023-12-14
- Last updated
- 2023-12-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06169930. Inclusion in this directory is not an endorsement.